Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL. (Q39493826)

12 September 2017

Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL. (English)

1 reference

12 September 2017

1 reference

A E Sayan

1

1 reference

12 September 2017

R Stanford

2

1 reference

12 September 2017

R Vickery

3

1 reference

12 September 2017

E Grigorenko

4

1 reference

12 September 2017

J Diesch

5

1 reference

12 September 2017

K Kulbicki

6

1 reference

12 September 2017

R Edwards

7

1 reference

12 September 2017

R Pal

8

1 reference

12 September 2017

P Greaves

9

1 reference

12 September 2017

I Jariel-Encontre

10

1 reference

12 September 2017

M Piechaczyk

11

1 reference

12 September 2017

M Kriajevska

12

1 reference

12 September 2017

J K Mellon

13

1 reference

12 September 2017

A S Dhillon

14

1 reference

12 September 2017

E Tulchinsky

15

1 reference

12 September 2017

language of work or name

English

0 references

publication date

8 August 2011

1 reference

12 September 2017

1 reference

12 September 2017

31

1 reference

12 September 2017

1493-1503

1 reference

12 September 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2011.336

12 September 2017

0 references

cites work

The ability of Fos family members to produce phenotypic changes in epithelioid cells is not directly linked to their transactivation potentials

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

Immediate and delayed effects of E-cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

The receptor tyrosine kinase ARK mediates cell aggregation by homophilic binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

An extracellular signal-regulated kinase 1- and 2-dependent program of chromatin trafficking of c-Fos and Fra-1 is required for cyclin D1 expression during cell cycle reentry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

Accumulation of Fra-1 in ras-transformed cells depends on both transcriptional autoregulation and MEK-dependent posttranslational stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

From the bakery to the brain business: developing inducible yeast models of human neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

AP-1: a double-edged sword in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

Ligand recognition and homophilic interactions in Tyro3: structural insights into the Axl/Tyro3 receptor tyrosine kinase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

FRA1 is a determinant for the difference in RAS-induced transformation between human and rat fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

Molecular pathogenesis of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

The Fos family of transcription factors and their role in tumourigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

Molecular pathogenesis and diagnostics of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

Invasion is a genetic program regulated by transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

AXL is an essential factor and therapeutic target for metastatic ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

AP-1 as a regulator of cell life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

Expression of axl in lung adenocarcinoma and correlation with tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

Deciphering AP-1 function in tumorigenesis: fra-ternizing on target promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

p73 supports cellular growth through c-Jun-dependent AP-1 transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

Transcriptional activation of the Axl and PDGFR-α by c-Met through a ras- and Src-independent mechanism in human bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

Fra-1 a target for cancer prevention or intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

AXL is a potential target for therapeutic intervention in breast cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

Nanoliter high-throughput RT-qPCR: a statistical analysis and assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.336

31 March 2020

Identifiers

DOI

10.1038/ONC.2011.336

1 reference

Dimensions Publication ID

12 September 2017

0 references

1 reference